Series CJorge Conde invests in therapeutics, diagnostics, life-sciences tools, and healthcare software as a general partner at Andreessen Horowitz.
Jorge Conde invests in therapeutics, diagnostics, life-sciences tools, and healthcare software as a general partner at Andreessen Horowitz.
Career
Jorge Conde studied at Harvard University (MBA, Harvard Business School), Harvard-MIT Division of Health Sciences and Technology (MS), and Johns Hopkins University (BA, Biology).
General Partner, Bio + Health at Andreessen Horowitz (a16z) from 2017-06 to PresentInvests in biotechnology and healthcare. Board roles include Asimov, Cartography, Dyno, Earli, Komodo Health, and Octant Bio.
Chief Strategy Officer, Chief Financial Officer and Chief Product Officer at Syros Pharmaceuticals from 2016-04 to 2017-03Held strategy, finance, and product leadership roles at a biotechnology company developing medicines through gene regulation.
Co-founder and Chief Executive Officer at Knome from 2007 to 2015Co-founded and led the human-genome interpretation company through its acquisition by Tute Genomics in 2015.MMarketing and Operations Manager at MedImmune from 2006 to 2007Worked in strategic marketing and operations.
Life Sciences Summer Associate at Flagship Ventures from 2005 to 2005
Biotechnology Investment Banker at Morgan Stanley from 2000 to 2003Advised biotechnology and genomics companies.Investing Announcements
Cosigns Received
Kevin ParkerCo-founder and CEO of Cartography Biosciences
Jorge Conde … and Sara Choi … took a bet on us and the idea, and helped us launch off the ground